SEQ Regulatory Services: Enhancing Compliance in Paediatric Medicinal Product Approvals

  • Comprehensive Regulatory Support for Paediatric Medicinal Product Approvals

  • Paediatric Investigation Plans (PIP), Waivers, and Deferrals

  • Unlocking Market Protection with Paediatric-Use Marketing Authorisations (PUMA)

Welcome to SEQ Regulatory Services, your partner in enhancing compliance for paediatric medicinal product approvals. Explore our comprehensive regulatory support designed to navigate the complexities of the Paediatric Regulation, ensuring the health of children in Europe.

 

 

  • Regulatory Support: SEQ offers comprehensive regulatory support for paediatric medicinal product approvals.

  • Paediatric Investigation Plans (PIP): Benefit from tailored PIP solutions, waivers, and deferrals to meet regulatory requirements.

  • Exclusive Development for Children: Learn about Paediatric-Use Marketing Authorisations (PUMA) for medicines exclusively developed for children, offering 10 years of market protection.

Comply with the Paediatric Regulation using SEQ’s regulatory expertise. Contact us at enquiries@nerin.co.im for personalized regulatory support.

 

Feel free to let me know if you have any further requests or adjustments!

  • Complying with the Paediatric Regulation: SEQ’s Regulatory Expertise

  • Paediatric Investigation Plans (PIP): Tailored Solutions by SEQ

  • Exclusive Development for Children: Paediatric-Use Marketing Authorisations (PUMA)